Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

Business Wire • Jan 30, 2026

BTX: Structural Flaws Cause Underperformance Against Peers (Rating Downgrade)

BlackRock Technology and Private Equity Term Trust is downgraded to a sell due to persistent underperformance and structural weaknesses. BTX trades at a 14.8% discount to NAV, reflecting challenges from private investment exposure and an option writing strategy that limits upside. The fund's 9.3% yield is unsustainable, as 100% of recent payouts are return of capital, eroding NAV and indicating poor earnings coverage.

Seeking Alpha • Jan 12, 2026

Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027

All-stock acquisition includes clinical-stage CD19/BCMA Dual-CAR T program Acquisition will expand existing advanced clinical-stage pipeline of amezalpat (PPAR ⍺ Antagonist, Phase 3-ready) and TPST-1495 (Dual Ep2/4 Antagonist, Phase 2 start expected near term) The anticipated preclosing equity financing and an investment commitment from Factor Bioscience is expected to extend Tempest's runway to mid 2027 and through potentially significant milestones Plan to proceed with execution of globally approved protocol for amezalpat in first-line HCC subject to additional resources or partnerships Matt Angel, Ph.D. to assume role of President and CEO and Stephen Brady to assume role of Chairman of the board of directors upon closing of the acquisition BRISBANE, Calif.

GlobeNewsWire • Nov 19, 2025

BTX: Cannot Support Dividend Payouts

BlackRock Technology and Private Equity Term Trust maintains a hold rating due to ongoing performance and distribution sustainability concerns. BTX trades at a 14.64% discount to NAV and offers a 9.5% yield, but struggles to generate sufficient earnings for reliable payouts. The fund's heavy tech allocation, option writing strategy, and sensitivity to high-interest rates limit growth and increase risk.

Seeking Alpha • Oct 24, 2025

5 Stocks Under $10 With Huge Dividends and King-Size Upside Potential

While most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

24/7 Wall Street • Oct 10, 2025

BTX Offers Diversification Into Private Equity

BTX offers a unique blend of technology-focused public and private equity exposure with a high 12.96% yield. The fund's underperformance versus peer CEFs is likely driven by challenges in pricing private equity holdings, which may not realize value until public exit or sale. Distributions are primarily return of capital and can vary from period to period, impacting tax planning and income stability, making BTX less suitable for investors seeking predictable income.

Seeking Alpha • Aug 17, 2025

5 Closed-End Fund Buys In The Month Of July 2025

With the month of July closing out, we are once again seeing the broader equity markets pushing to new all-time highs. As we enter into new all-time highs, we appear to be looking quite stretched on valuations, and CEF discounts have been narrowing.

Seeking Alpha • Aug 14, 2025

A 13% Dividends From AI? Here Are The Tickers

By now you've no doubt heard the argument that AI is a bubble, and there's no way Big Tech will make a significant profit from it, given the massive amounts of cash they've already piled in.

Forbes • Jul 31, 2025

5 Stocks Trading Under $10 That Pay Massive Monthly Ultra-High-Yield Dividends

While most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

24/7 Wall Street • Jul 20, 2025

BlackRock Technology and Private Equity Term Trust (BTX) Announces Expiration and Preliminary Results of Tender Offer

NEW YORK--(BUSINESS WIRE)---- $BTX--BlackRock Technology and Private Equity Term Trust (the “Fund”) announced today the expiration and preliminary results of the Fund's tender offer (the “Tender Offer”) for up to 50% of its outstanding common shares (the “Shares”). The Tender Offer commenced on June 9, 2025 and expired at 11:59 p.m. Eastern time on July 8, 2025. Based on preliminary information, the number of Shares properly tendered and not withdrawn is noted in the table below. Fund Name Ticker CUSIP.

Business Wire • Jul 9, 2025